What is Orgenesis Inc?
, a biotech company, focuses on cell and gene therapies in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 5.68M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.